Viking Therapeutics Inc (VKTX)
76.97
+1.21
(+1.60%)
USD |
NASDAQ |
May 03, 16:00
76.97
0.00 (0.00%)
After-Hours: 20:00
Viking Therapeutics Max Drawdown (5Y): 89.26% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 89.26% |
March 31, 2024 | 89.26% |
February 29, 2024 | 89.26% |
January 31, 2024 | 89.26% |
December 31, 2023 | 89.26% |
November 30, 2023 | 89.26% |
October 31, 2023 | 89.26% |
September 30, 2023 | 89.26% |
August 31, 2023 | 89.26% |
July 31, 2023 | 89.26% |
June 30, 2023 | 89.26% |
May 31, 2023 | 89.26% |
April 30, 2023 | 89.26% |
March 31, 2023 | 89.26% |
February 28, 2023 | 89.26% |
January 31, 2023 | 89.26% |
December 31, 2022 | 89.26% |
November 30, 2022 | 89.26% |
October 31, 2022 | 89.26% |
September 30, 2022 | 89.26% |
August 31, 2022 | 89.26% |
July 31, 2022 | 89.26% |
June 30, 2022 | 89.26% |
May 31, 2022 | 90.41% |
April 30, 2022 | 90.41% |
Date | Value |
---|---|
March 31, 2022 | 90.41% |
February 28, 2022 | 90.41% |
January 31, 2022 | 90.41% |
December 31, 2021 | 90.41% |
November 30, 2021 | 90.41% |
October 31, 2021 | 90.41% |
September 30, 2021 | 90.41% |
August 31, 2021 | 90.41% |
July 31, 2021 | 90.41% |
June 30, 2021 | 90.41% |
May 31, 2021 | 90.41% |
April 30, 2021 | 90.41% |
March 31, 2021 | 90.41% |
February 28, 2021 | 90.41% |
January 31, 2021 | 90.41% |
December 31, 2020 | 90.41% |
November 30, 2020 | 90.41% |
October 31, 2020 | 90.41% |
September 30, 2020 | 90.41% |
August 31, 2020 | 90.41% |
July 31, 2020 | 90.41% |
June 30, 2020 | 90.41% |
May 31, 2020 | 90.41% |
April 30, 2020 | 90.41% |
March 31, 2020 | 90.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.26%
Minimum
Jun 2022
90.41%
Maximum
May 2019
89.97%
Average
90.41%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Eli Lilly and Co | 22.48% |
Pfizer Inc | 54.78% |
Madrigal Pharmaceuticals Inc | 82.20% |
Akero Therapeutics Inc | -- |
Terns Pharmaceuticals Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 44.44 |
Beta (5Y) | 1.123 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 125.1% |
Historical Sharpe Ratio (5Y) | 0.4554 |
Historical Sortino (5Y) | 1.892 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.53% |